Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NY-ESO-1 Targeted T Cells in Advanced Oesophagogastric Cancer
NCT01795976Phase 2Terminated
- Start
- Oct 2014
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of NY-ESO-1 targeted T cells in oesophago-gastric cancer. Started Oct 2014; status: terminated.
02
Drugs
NY-ESO-1 targeted T cells
03
Conditions
oesophago-gastric cancer
Beyond the preview
Go deeper on NCT01795976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795976.